» Articles » PMID: 7574237

Renal Cell Carcinoma and Erythropoietin

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 1995 Nov 1
PMID 7574237
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.

Miyake M, Goodison S, Lawton A, Zhang G, Gomes-Giacoia E, Rosser C J Hematol Oncol. 2013; 6:65.

PMID: 24004818 PMC: 3844377. DOI: 10.1186/1756-8722-6-65.


Functional significance of erythropoietin in renal cell carcinoma.

Morais C, Johnson D, Vesey D, Gobe G BMC Cancer. 2013; 13:14.

PMID: 23305401 PMC: 3554558. DOI: 10.1186/1471-2407-13-14.


[Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].

Schenck M, Borgermann C, Jager T, Dorp F, Sperling H, Rubben H Urologe A. 2007; 46(5):528-34.

PMID: 17356836 DOI: 10.1007/s00120-007-1313-x.